Trolamine salicylate 0.1 MG/MG Medicated Patch — RxCUI 2722418
RxNorm drug concept · Semantic clinical drug
RxCUI 2722418
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
0 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2722418
Official nameTrolamine salicylate 0.1 MG/MG Medicated Patch
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astea-salicylate 10 % Medicated Patch; trolamine salicylate 10 % Medicated Patch
FDA products mapped1
Package NDCs mapped0
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How Trolamine salicylate 0.1 MG/MG Medicated Patch Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Trolamine salicylate 0.1 MG/MG Medicated Patch
RxCUI 2722418 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Trolamine salicylate
38866IN
-
Trolamine salicylate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Salicor
2722419BN
-
Salicor
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Trolamine salicylate Medicated Patch
2722417SCDF -
Trolamine salicylate Topical Product
1163392SCDG -
Trolamine salicylate Medicated Patch [Salicor]
2722422SBDF -
Salicor Topical Product
2722421SBDG -
Medicated Patch
1792831DF -
Topical Product
1151122DFG
-
Trolamine salicylate Medicated Patch
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Trolamine salicylate 0.1 MG/MG
329260SCDC -
Trolamine salicylate 0.1 MG/MG Medicated Patch [Salicor]
2722423SBD -
Trolamine salicylate 0.1 MG/MG [Salicor]
2722420SBDC
-
Trolamine salicylate 0.1 MG/MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Trolamine salicylate 0.1 MG/MG
SCDC · 329260 -
Trolamine salicylate Medicated Patch
SCDF · 2722417 -
Trolamine salicylate Topical Product
SCDG · 1163392
Brand-Name Concepts
-
Trolamine salicylate 0.1 MG/MG Medicated Patch [Salicor]
SBD · 2722423 -
Trolamine salicylate 0.1 MG/MG [Salicor]
SBDC · 2722420 -
Trolamine salicylate Medicated Patch [Salicor]
SBDF · 2722422 -
Salicor Topical Product
SBDG · 2722421 -
Salicor
BN · 2722419
📦 FDA Products & Package NDCs
1 product · 0 package NDCs
No package NDCs are mapped to this concept in the current snapshot. Missing rows here mean the openFDA export did not annotate a listing with this RxCUI — never that no product exists.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.